Jason Weil

March 29, 2019 | The Legal Intelligencer

For pharmaceutical inventions, which usually undergo a lengthy FDA approval process before any drug can be sold, the most valuable portion of patent term is at the end of the patent's life, after FDA approval.

By Matthew A. Pearson, Angie Verrecchio and Jason Weil

9 minute read

April 04, 2017 | The Legal Intelligencer

At first blush, a discussion of the rules governing venue of patent infringement lawsuits sounds like a boring topic. But those rules have led to some unexpected real-world situations.

By Dianne Elderkin and Jason Weil

15 minute read